OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Michelle Mielke

2 Projects | 1 Researchers | $106,960 Invested

2013

Mayo Clinic Rochester

Michelle Mielke, PhD

Evaluation of changes in plasma ceramides and amino compounds with an mTOT Modulator Insulin Sensitizer in AD patients

  • Funding Amount: $6,960
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Target: Mitochondria/Metabolic Function
  • Status: Closed

2012

Mayo Clinic Rochester

Michelle Mielke, PhD

Plasma lipidomic and alpha-synuclein comparison of individuals with alpha-synuclein, amyloid, or normal pathology

  • Funding Amount: $100,000
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Status: Closed